AVXL logo

AVXL

Anavex Life Sciences Corp.

$9.64
+$0.42(+4.56%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$818.57M
Volume
882.95K
52W Range
$4.93 - $14.44
Target Price
$34.33
Order:

Income Statement

MetricTrendChart
2015
Sep
2016
Sep
2017
Sep
2018
Sep
2019
Sep
2020
Sep
2021
Sep
2022
Sep
2023
Sep
2024
Sep
REVENUE
Total Revenue
$-5.0M$-5.8K--$-30.9K$-151.1K----------
Total Revenue
$-5.0M$-5.8K--$-30.9K$-151.1K----------
GROSS PROFIT
Gross Profit
$-5.0M$-5.8K--$-30.9K$-151.1K----------
OPERATING EXPENSES
Operating Expenses
$-7.1M$-15.6M$-15.7M$-19.3M$-29.1M$31.1M$-42.0M$51.0M$55.8M$52.9M
Research & Development
$2.3M$7.3M$10.7M$13.3M$22.3M$25.2M$33.0M$37.9M$43.7M$41.8M
Research Expense
$2.3M$7.3M$10.7M$13.3M$22.3M$25.2M$33.0M$37.9M$43.7M$41.8M
Selling, General & Administrative
$4.8M$8.3M$5.0M$6.0M$6.8M$5.9M$9.0M$13.1M$12.0M$11.0M
Selling & Marketing Expenses
$-2.7M------------------
General & Administrative Expenses
$4.8M$8.3M$5.0M$6.0M$6.8M$5.9M$9.0M$13.1M$12.0M$11.0M
Salaries & Wages
$-414.0K$-5.1M$-4.1M$-5.5M$-6.4M----$18.4M$16.4M$9.4M
Other Operating Expenses
--------------$73.0K$118.0K$125.0K
OPERATING INCOME
Operating income
$-12.1M$-15.6M$-15.7M$-19.4M$-29.3M$-31.1M$-42.0M$-51.0M$-55.8M$-52.9M
EBITDA
$-12.1M$-14.7M$-13.4M$-17.2M$-26.2M$-30.9M$-37.6M$-47.6M$-54.0M$-54.1M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$71.8K--------$-180.0K$-26.3K$-947.0K$-6.5M$-7.3M
Intinc
--$924.9K$2.2M$2.0M$2.8M----------
Net Non-Operating Interest Income/Expense
$-71.8K$924.9K$2.2M$2.0M$2.8M$180.0K$26.3K$-947.0K$6.5M$7.3M
Other Income/Expense
$-7.4M$-61.2K--$-2.2M$-115.8K$-4.5M$-4.6M$2.4M$2.7M--
Other Special Charges
$7.4M$61.2K--$2.2M$115.8K$4.5M$4.6M$3.3M----
SPECIAL ITEMS
Restructring And Mn A Income
$-4.5M------------------
Special Income Charges
$4.5M------------------
PRE-TAX INCOME
EBIT
$-12.1M$-14.7M$-13.4M$-17.2M$-26.2M$-30.9M$-37.6M$-47.6M$-54.0M$-54.1M
Pre-Tax Income
$-12.1M$-14.7M$-13.4M$-17.2M$-26.2M$-26.3M$-37.6M$-47.6M$-47.5M$-43.0M
INCOME TAX
Tax Provision
$5.0K$29.6K$59.6K$72.7K$82.2K$22.7K$268.0K$358.0K$7.0K$-3.8M
NET INCOME
Net Income
$-12.1M$-14.7M$-13.5M$-17.3M$-26.3M$-26.3M$-37.9M$-48.0M$-47.5M$-43.0M
Net Income (Continuing Operations)
$-12.1M$-14.7M$-13.5M$-17.3M$-26.3M$-26.3M$-37.9M$-48.0M$-47.5M$-43.0M
Net Income (Discontinued Operations)
$-12.1M$-14.7M$-13.5M$-17.3M$-26.3M$-26.3M$-37.9M$-48.0M$-47.5M$-43.0M
Net Income (Common Stockholders)
$-12.1M$-14.7M$-13.5M$-17.3M$-26.3M$-26.3M$-37.9M$-48.0M$-47.5M$-43.0M
Normalized Income
------------------$-46.8M
TOTALS
Total Expenses
$-7.1M$-15.6M$-15.7M$-19.3M$-29.1M$31.1M$-42.0M$51.0M$55.8M$52.9M
SHARE & EPS DATA
Average Shares Outstanding
$4.6M$35.2M$40.8M$44.7M$48.9M$58.2M$69.8M--$79.8M$83.5M
Average Shares Outstanding (Diluted)
$4.6M$35.1M$40.8M$44.8M$48.7M$58.2M$69.8M--$79.8M$83.5M
Shares Outstanding
$8.7M$39.6M$44.2M$46.6M$56.1M$67.0M$76.0M$85.9M$82.1M$84.8M
Basic EPS
$-2.6$-0.42------$-0.45$-0.54--$-0.60$-0.52
Basic EPS (Continuing Operations)
----------$-0.45$-0.54--$-0.60$-0.52
Diluted EPS
$-2.6$-0.42$-0.33$-0.39$-0.54$-0.45$-0.54--$-0.60$-0.52
Diluted EPS (Continuing Operations)
----------------$-0.60$-0.52
OTHER METRICS
Fees
$-5.0M$-5.8K--$-30.9K$-151.1K----------
Net Operating Interest Income Expense
$-71.8K$11.3K$88.1K$255.1K$207.3K----------
Other Gand A
$4.8M$8.3M$5.0M$6.0M$6.8M$5.9M$9.0M$13.1M$12.0M$11.0M
Other Taxes
------$-72.7K$-82.2K$22.7K$267.6K$358.0K----
Rent And Landing Fees
$4.8M$8.3M$5.0M$6.0M$6.8M$233.4K$130.8K$72.9K----
Restruct
$-4.5M------------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2AVXL$9.64+4.6%882.95K
3
4
5
6

Get Anavex Life Sciences Corp. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.